GBT NASDAQ
Global Blood Therapeutics, Inc.
1W: +0.5%
1M: +1.0%
3M: +104.5%
1Y: +162.2%
3Y: +39.8%
5Y: +120.9%
$68.49
Last traded 2022-10-04 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$235M
Revenue
+42.5% YoY
$-326M
Net Income
-22.6% YoY
$-251M
Free Cash Flow
-16.3% YoY
98.0%
Gross Margin
-103.3%
Op. Margin
-115.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-150.4%
ROA-43.9%
ROIC-90.5%
Valuation
P/E-14.2
P/B21.9
EV/EBITDA-7.8
Leverage
Debt/Equity5.56
Current Ratio6.88
Interest Cov.-12.0x
Quality Scores
Piotroski F2/9
Altman Z-0.77
Beneish M8.32